Ledger.Open graph →
SEC Form D · Amendment · filed October 31, 2019

MIRAGEN THERAPEUTICS, INC

Offering
$5.0M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOULDER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Paul Lidsky · New York, NYDirectorAnish J. Parvatanini · CHICAGO, ILDirectorRoss A. Buhrdorf · Terrell, TXDirectorJames, Iii B. Mcginty · Terrell, TXDirectorArlene M. Morris · Boulder, CODirectorPhilip B. Palmer · SAVANNAH, GAExec · DirectorPaul D. Rubin · Boulder, COExecAnthony B. Lennen · Indianapolis, INExecAmy D. Glover · Indianapolis, INExec · DirectorDavid Ertel · Coral Gables, FLDirectorJoseph L. Turner · San Ramon, CADirectorTomas N. Diaz Mathe · Irving, TXDirectorChristopher D. Bowden · Boulder, CODirectorNull Assure Fund Management Ii · Salt Lake City, UTDirectorArjuna J. Ariathurai · CHICAGO, ILDirectorPaul G. Smith · Omaha, NEDirectorHoward D. Ellis · Overland Park, KSExecWilliam S. Marshall · Boulder, COExec · DirectorKevin E. Koch · Boulder, CODirectorJason A. Leverone · Boulder, COExecAaron Greenwald · New York, NYDirectorJeffrey S. Hatfield · Boulder, CODirectorThomas E. Hughes · Boulder, CODirectorWalter Cook · New York, NYExecMark Carhart · New York, NYDirectorQuentin W. Kahrau · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗